Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis

PHASE2CompletedINTERVENTIONAL
Enrollment

252

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

August 31, 2016

Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG

Rasagiline

DRUG

Placebo

a sugar pill manufactured to mimic Rasagiline 1 mg tablet

Trial Locations (15)

13353

Department of Neurology, Humboldt University, Berlin

30625

Department of Neurology, Medical School Hannover, Hanover

44789

Neurologische Universitätsklinik Bergmannsheil, Bochum

89081

Department of Neurology, University of Ulm, Ulm

91054

Department of Neurology, University of Wuerzburg, Würzburg

D-81675

Department of Neurology, Technische Universität München, Munich

D-93053

Department of Neurology, Universty of Regensburg, Regensburg

D-65191

Department of Neurology, Deutsche Klinik für Diagnostik, Wiesbaden

D-37073

Department of Neurology, University of Goettingen, Göttingen

D-18147

Department of Neurology, University of Rostock, Rostock

D-53105

Department of Neurology, Universty of Bonn, Bonn

D-48149

Department of Neurology, Universty of Muenster, Münster

D-01307

Department of Neurology, TU Dresden, Dresden

06097

Department of Neurology, University of Halle-Wittenberg, Halle

D-07747

Department of Neurology, University of Jena, Jena

All Listed Sponsors
lead

University of Ulm

OTHER

NCT01879241 - Study of Rasagiline in Patients With Amyotrophic Lateral Sclerosis | Biotech Hunter | Biotech Hunter